YunChang Collocystis in treatment of Functional constipation of deficiency of both vital energy and yin with nterior poison syndrome:a multi-center, randomized, controlled, double-blinded trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000525

Enrollment

Unknown

Registered

2009-06-16

Start date

2006-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional constipation

Interventions

Group A:YunChang Collocystis two pills (0.35g/pill) and YunChang Collocystis imitation, one pill, three times a day

Group B:YunChang Collocystis, as a dose of three pills(0.35g/pill), three times a day

Group C:placebo, three pills (0.35g/pill), three times a day

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18–65years; 2. Presenting with functional constipation, defined in accordance with the Rome diagnostic criteria II; 3. All subjects gave written informed consents.

Exclusion criteria

Exclusion criteria: 1. Organic disorders of the digestive tract; 2. Anorectal lesions; abnormality at barium enema or colonoscopy; 3. Abnormal laboratory tests (routine laboratory examinations); 4. Inflammatory bowel disease; 5. Pregnant women or women in lactation ; 6. Use of drugs to treat functional constipation in recently two weeks; 7. Allergy or allergy to the drug; 8. Fecal occult blood positive ; 9. Metabolic neurological, and psychiatric illnesses.

Design outcomes

Primary

Measure	Time frame
Frequency of defecation;Hard stools;Straining at defecation;	—

Secondary

Measure	Time frame
abdominal distension;dry mouth,parcheed lips;lassitude;	—

Countries

China

Contacts

Public ContactZongwen Huang

huangzongwen@medmail.com+86 028 81812725

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026